Chronic renal disease is a worldwide major health problem, with increasing incidence, prevalence, high costs, and poor outcomes. 1 Mortality among patients with CKD and ESRD remains high due to its association with the occurrence of ischemic heart disease (IHD). 2 Numerous data show a close relationship between inflammation and cardiovascular morbidity and mortality. Hs-CRP is an important indicator and diagnostic tool for systemic inflammation. It has been found that Interleukin-6 and tumour necrosis factor-α are proinflammatory cytokines that can stimulate CRP synthesis in the liver. 3 All these biomarkers are very useful in the prediction of cardiovascular complications and mortality in ESRD patients. 4 Renal function impairment frequently leads to IHD. There are many traditional risk factors associated with IHD. Nowadays non-traditional CKD-specific risk factors for IHD appeared. Among the most important non-conventional risk factors are uremic toxins (UTs). Despite many studies either

Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles under the following conditions: Creative Commons Attribution-Share Alike 4.0 International Public License (CC BY-SA 4.0).